The U.S. Food and Drug Administration's accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients' lives?
High-school courses that let students pursue advanced study in mathematics and science should be more in-depth, and should also be made more widely available to poor and minority students, a report ...
Researchers looking for clues about why some types of cancer are on the rise in younger adults say they’ve found an interesting lead: a connection to accelerated biological aging. Aging is the major ...
Less than half of the cancer therapies that were granted accelerated approval by the FDA between 2013 and 2017 showed a clinical benefit in a confirmatory trial within the next five years. That is the ...
That’s according to new research presented this week at the American Association for Cancer Research (AACR) Annual Meeting in San Diego, California. “Historically, both cancer and aging have been ...
Getting your Trinity Audio player ready... By CARLA K. JOHNSON (AP Medical Writer) The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results